xoma corp (XOMA:NASDAQ GM)

Executive Profile*

Background*

Mr. John W. Varian has been the Chief Executive Officer of XOMA Corporation since January 5, 2012. Mr. Varian served as Interim Chief Executive Officer of XOMA Corporation from August 31, 2011 to January 5, 2012. Mr. Varian served as the Chief Operating Officer of ARYx Therapeutics Inc. from December 2003 to 2011. Mr. Varian served as Chief Financial Officer of ARYx Therapeutics, Inc. from April 2006 to March 10, 2011. Mr. Varian served as a Vice President of Aryx Therapeutics ... Inc. He served as the Chief Financial Officer and Interim Chief Financial Officer of Deltagen Inc. since April 21, 2003. Mr. Varian served as the Chief Financial Officer of Genset S.A., a Paris-based genomics company, from 2000 to 2002. Mr. Varian served as Vice President and Chief Financial Officer Neurex corporation from June 1997 to October 1998. During his tenure at Neurex, he was responsible for enhancing its visibility with Wall Street and the pharmaceutical industry. Prior to joining Genset S.A., he served as Senior Vice President of Finance and Administration at Elan Pharmaceuticals. He was appointed to that position in 1998 when Elan Corp. acquired Neurex, Inc., where he served as Chief Financial Officer since 1997. From 1991 to 1997, Mr. Varian served as the Chief Financial Officer of Anergen Inc. Prior to joining Anergen Inc., he spent approximately 10 years as a certified public accountant, most recently as a senior manager in the San Francisco office of Ernst & Young. He has been a Director of XOMA Ltd. since December 8, 2008. Mr. Varian served as a Director of Nventa Biopharmaceuticals Corporation since May 2008. He is a founding member of the Bay Area Bioscience Center and served as Chairman of the Association of Bioscience Financial Officers International Conference. He has been a frequent guest lecturer for various universities, including University of California, Berkeley, University of California, Santa Barbara, and California Polytechnic State University. Mr. Varian holds a BBA degree from Western Michigan University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
XOMA:US	$4.09 USD	-0.04

COMPETITOR COMPENSATION